HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francesco Verderame Selected Research

Francesco Verderame Research Topics

Disease

8Neoplasms (Cancer)
03/2024 - 06/2018
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 02/2003
6Prostatic Neoplasms (Prostate Cancer)
12/2019 - 01/2015
5Breast Neoplasms (Breast Cancer)
01/2022 - 07/2006
4Neoplasm Metastasis (Metastasis)
03/2024 - 01/2015
3Hepatocellular Carcinoma (Hepatoma)
03/2024 - 11/2023
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2024 - 11/2019
3Triple Negative Breast Neoplasms
02/2024 - 09/2023
3Human Influenza (Influenza)
11/2023 - 01/2020
2Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 03/2006
2Brain Neoplasms (Brain Tumor)
06/2022 - 01/2019
2Neutropenia
01/2021 - 09/2008
2Febrile Neutropenia
01/2021 - 09/2008
1Mesothelioma
02/2024
1Lung Neoplasms (Lung Cancer)
12/2023
1Disease Progression
11/2023
1Heart Arrest (Cardiac Arrest)
01/2021
1Multiple Organ Failure (MODS)
01/2021
1Enterocolitis
01/2021
1Dehydration (Water Stress)
01/2021
1Pancytopenia
01/2021
1Sudden Death
01/2021
1Pneumonia (Pneumonitis)
01/2021
1Pulmonary Embolism
01/2021
1Respiratory Insufficiency (Respiratory Failure)
01/2021
1Thrombocytopenia (Thrombopenia)
01/2021
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2021
1Sepsis (Septicemia)
01/2021
1Hepatitis
01/2021
1COVID-19
01/2020
1Osteolysis
04/2018
1Hemangiosarcoma (Angiosarcoma)
03/2017
1Adenocarcinoma
03/2006

Drug/Important Bio-Agent (IBA)

5NivolumabIBA
02/2024 - 01/2019
5Immune Checkpoint InhibitorsIBA
11/2023 - 01/2020
5Vinorelbine (Navelbine)FDA LinkGeneric
01/2020 - 02/2003
4Etoposide (VP 16)FDA LinkGeneric
02/2024 - 11/2019
4PlatinumIBA
06/2022 - 01/2019
4Docetaxel (Taxotere)FDA Link
02/2016 - 04/2014
3Paclitaxel (Taxol)FDA LinkGeneric
02/2024 - 09/2023
3durvalumabIBA
06/2022 - 11/2019
3Cisplatin (Platino)FDA LinkGeneric
01/2021 - 02/2003
3Abiraterone AcetateIBA
02/2016 - 05/2015
2atezolizumabIBA
02/2024 - 09/2023
2Carboplatin (JM8)FDA LinkGeneric
02/2024 - 01/2021
2Biomarkers (Surrogate Marker)IBA
02/2024 - 12/2023
2GemcitabineFDA Link
04/2014 - 02/2003
1Yttrium-90IBA
03/2024
1Sorafenib (BAY 43-9006)FDA Link
02/2024
1130-nm albumin-bound paclitaxelIBA
09/2023
1ribociclibIBA
01/2022
1Epidermal Growth Factor (EGF)IBA
01/2022
1Hormones (Hormone)IBA
01/2022
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2022
1Aromatase InhibitorsIBA
01/2022
1Influenza Vaccines (Influenza Vaccine)FDA Link
01/2021
1tremelimumabIBA
01/2021
1Radium-223IBA
12/2019
1eribulinFDA Link
01/2019
1Therapeutic UsesIBA
04/2018
1RadiopharmaceuticalsIBA
04/2018
1RadiumIBA
04/2018
1enzalutamideIBA
07/2015
1cabazitaxelFDA Link
07/2015
1nasIBA
07/2015
1abirateroneIBA
01/2015
1Trastuzumab (Herceptin)FDA Link
04/2014
1AcidsIBA
07/2006
1Fluorouracil (Carac)FDA LinkGeneric
07/2006
1Cetuximab (Erbitux)FDA Link
03/2006
1Irinotecan (Camptosar)FDA LinkGeneric
03/2006
1Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2006
1IfosfamideFDA LinkGeneric
02/2003

Therapy/Procedure

10Therapeutics
12/2023 - 03/2006
5Castration
12/2019 - 01/2015
5Drug Therapy (Chemotherapy)
01/2019 - 03/2006
4Immunotherapy
02/2024 - 01/2020
2Radiotherapy
06/2022 - 12/2019
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
06/2018 - 03/2017
1Investigational Therapies (Experimental Therapy)
12/2023
1Cranial Irradiation
06/2022
1Off-Label Use
04/2018
1Intravenous Infusions
03/2006